NCT02618564

The Use of Sennosides With Pico Salax in Bowel Preparation for Colonoscopy: a Study of Optimal Dose and Timing

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Queen's University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to evaluate sennosides as an adjunct to sodium picosulfate magnesium citrate (Pico Salax) in preparation for colonoscopy. We will compare different doses and administration times. The primary outcome is number of bowel motions produced. Secondary outcomes include the quality of bowel cleansing and patient tolerability.

Detailed description

We will compare different doses and administration times in patients booked for morning colonoscopy. The primary outcome is number of bowel motions produced in total by the sennosides. Secondary outcomes include the quality of bowel cleansing and patient tolerability.

Conditions

• Colonoscopy Preparation Outcome

Interventions

Type	Name	Description
DRUG	Sennosides	Each group will be assigned different doses of sennosides and varying times of administration

Timeline

• Start date: 2016-01-01
• Primary completion: 2017-08-01
• Completion: 2017-08-01
• First posted: 2015-12-01
• Last updated: 2018-05-09

Locations

2 sites across 1 country: Canada